Literature DB >> 6125490

Metronidazole exhibits no clastogenic activity in a double-blind cross-over study on Crohn's patients.

F Mitelman, B Strömbeck, B Ursing, O Nordle, B Hartley-Asp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6125490     DOI： 10.1111/j.1601-5223.1982.tb00859.x

Source DB:  PubMed          Journal:  Hereditas        ISSN： 0018-0661            Impact factor:   3.271


× No keyword cloud information.
  3 in total

1.  Antibiotics for induction and maintenance of remission in Crohn's disease.

Authors:  Cassandra M Townsend; Claire E Parker; John K MacDonald; Tran M Nguyen; Vipul Jairath; Brian G Feagan; Reena Khanna
Journal:  Cochrane Database Syst Rev       Date:  2019-02-07

2.  Genotoxicity revaluation of three commercial nitroheterocyclic drugs: nifurtimox, benznidazole, and metronidazole.

Authors:  Annamaria Buschini; Lisa Ferrarini; Susanna Franzoni; Serena Galati; Mirca Lazzaretti; Francesca Mussi; Cristina Northfleet de Albuquerque; Tânia Maria Araújo Domingues Zucchi; Paola Poli
Journal:  J Parasitol Res       Date:  2009-10-21

3.  No cytogenetic effects of quinolone treatment in humans.

Authors:  F Mitelman; A M Kolnig; B Strömbeck; R Norrby; B Kromann-Andersen; P Sommer; J Wadstein
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.